What is the address of CEDAV Med?

The registered office of CEDAV Med is located at Clos de l' Epaisse Haie(EL) 4, 7050 Jurbise.

Is CEDAV Med still active?

Yes. According to the CBE (29 October 2026) CEDAV Med is active, legal situation “Normale toestand”, started on 10 September 2021.

Is CEDAV Med registered on Peppol?

Yes, CEDAV Med is registered on the Peppol network with ID 0208:0773725646.

What is the enterprise number of CEDAV Med?

The enterprise number of CEDAV Med is BE0773725646.

When was CEDAV Med founded?

CEDAV Med was founded on 10 September 2021.

Who are the directors of CEDAV Med?

According to the 2025 annual accounts, the directors of CEDAV Med are: Cristina Valentina Popescu.

Is CEDAV Med a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 September 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CEDAV Med make in 2025?

CEDAV Med posted a profit after taxes of € 121,179 in financial year 2025.

What is the revenue of CEDAV Med?

As a small company, CEDAV Med is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 202,446.

CEDAV Med (Private Limited) - Jurbise - BE0773725646

Dossier CEDAV Med, printed on 29 October 2026 from databakkes.be/en/0773725646/cedav-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CEDAV Med from Jurbise, company number BE0773725646, closed financial year 2025 with a result of € 121,179 after tax. For that financial year CEDAV Med recorded a gross margin of € 202,446 and equity of € 132,353. Compared with financial year 2024, the result moved from € 121,173 to € 121,179. Profitable, and profit is growing. The buffer shrank hard: equity is 55 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Shrank hard

€ 132,353

▼ 55% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 121,179

Profit after tax over the fiscal year.

Cash in the bank

€ 209,179

▲ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 285,896 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 51,311

▼ 10% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 72,801

▼ 28% vs 2024

€ 29,040 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 222

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 33,719

▲ 151% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 86,694 Gross margin 2022: € 86,694 First fiscal year in the series	€ 141,717 Gross margin 2023: € 141,717 ▲ 63% vs 2022 (€ 86,694) Favourable step	€ 196,086 Gross margin 2024: € 196,086 ▲ 38% vs 2023 (€ 141,717) Favourable step	€ 202,446 Gross margin 2025: € 202,446 ▲ 3% vs 2024 (€ 196,086) Favourable step	▲ 3%
Profit after taxes	€ 49,602 Profit after taxes 2022: € 49,602 First fiscal year in the series	€ 88,720 Profit after taxes 2023: € 88,720 ▲ 79% vs 2022 (€ 49,602) Favourable step	€ 121,173 Profit after taxes 2024: € 121,173 ▲ 37% vs 2023 (€ 88,720) Favourable step	€ 121,179 Profit after taxes 2025: € 121,179 Unchanged (€ 121,173) Favourable step
Equity	€ 87,176 Equity 2022: € 87,176 First fiscal year in the series	€ 175,896 Equity 2023: € 175,896 ▲ 102% vs 2022 (€ 87,176) Favourable step	€ 297,069 Equity 2024: € 297,069 ▲ 69% vs 2023 (€ 175,896) Favourable step	€ 132,353 Equity 2025: € 132,353 ▼ 55% vs 2024 (€ 297,069) Unfavourable step	▼ 55%
Total debts	€ 199,885 Total debts 2022: € 199,885 First fiscal year in the series	€ 175,015 Total debts 2023: € 175,015 ▼ 12% vs 2022 (€ 199,885) Favourable step	€ 115,931 Total debts 2024: € 115,931 ▼ 34% vs 2023 (€ 175,015) Favourable step	€ 319,116 Total debts 2025: € 319,116 ▲ 175% vs 2024 (€ 115,931) Unfavourable step	▲ 175%
Cash	€ 49,149 Cash 2022: € 49,149 First fiscal year in the series	€ 62,667 Cash 2023: € 62,667 ▲ 28% vs 2022 (€ 49,149) Favourable step	€ 134,269 Cash 2024: € 134,269 ▲ 114% vs 2023 (€ 62,667) Favourable step	€ 209,179 Cash 2025: € 209,179 ▲ 56% vs 2024 (€ 134,269) Favourable step	▲ 56%
Retained profit	€ 67,176 Retained profit 2022: € 67,176 First fiscal year in the series	€ 155,896 Retained profit 2023: € 155,896 ▲ 132% vs 2022 (€ 67,176) Favourable step	€ 277,069 Retained profit 2024: € 277,069 ▲ 78% vs 2023 (€ 155,896) Favourable step	€ 112,353 Retained profit 2025: € 112,353 ▼ 59% vs 2024 (€ 277,069) Unfavourable step	▼ 59%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 285,896 Dividend 2025: € 285,896 Unchanged (€ 0) Unchanged
Bank debt	€ 108,925 Bank debt 2022: € 108,925 First fiscal year in the series	€ 129,135 Bank debt 2023: € 129,135 ▲ 19% vs 2022 (€ 108,925) Unfavourable step	€ 101,255 Bank debt 2024: € 101,255 ▼ 22% vs 2023 (€ 129,135) Favourable step	€ 72,801 Bank debt 2025: € 72,801 ▼ 28% vs 2024 (€ 101,255) Favourable step	▼ 28%
Balance sheet total	€ 287,061 Balance sheet total 2022: € 287,061 First fiscal year in the series	€ 350,911 Balance sheet total 2023: € 350,911 ▲ 22% vs 2022 (€ 287,061) Unchanged	€ 413,000 Balance sheet total 2024: € 413,000 ▲ 18% vs 2023 (€ 350,911) Unchanged	€ 451,468 Balance sheet total 2025: € 451,468 ▲ 9% vs 2024 (€ 413,000) Unchanged	▲ 9%

Key figures of CEDAV Med, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CEDAV Med?

What happened at CEDAV Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 121,179. filed late Source: NBB ↗
Sep 10, 2021 New establishment in Jurbise. KBO
2021 Cristina Valentina Popescu became a director. NBB
Sep 10, 2021 Start of the company according to the CBE. KBO

In short

From € 49,602 profit in 2022 to € 121,179 profit in 2025.

Paid € 108,298 in corporate taxes since 2022.

Best year ever: 2025, with € 121,179 profit.

Paid out € 285,896 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Cristina Valentina Popescu

CEDAV Med

Behind CEDAV Med is Cristina Valentina Popescu.

Directors

According to the 2025 annual accounts

Cristina Valentina Popescu

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Clos de l' Epaisse Haie(EL) 4

7050 Jurbise

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Ets LEBRUN

Wise Engineering

€ 126,317 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0773.725.646
VAT number: BE 0773.725.646
Registered office: Clos de l' Epaisse Haie(EL) 4, 7050 Jurbise
Names & denominations: CEDAV Med
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 September 2021
Peppol: Active · Active since 4 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗